Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellect Biotechnology Ltd. (a foreign private issuer) covers the month of January 2018. The filing discloses a registered direct offering of American Depositary Shares (ADSs) entered into on January 29, 2018, with an expected closing date of January 31, 2018.
Key Financial Metrics
The filing details a capital raise rather than operational financial performance. Key transaction metrics include:
- Gross Proceeds: Approximately $4.0 million.
- Shares Issued: 484,848 ADSs.
- Purchase Price: $8.25 per ADS.
- Warrants Issued: Unregistered warrants to purchase 266,667 ADSs.
- Placement Agent Fees: 7% of the aggregate purchase price plus a $25,000 expense allowance.
- Placement Agent Warrants: Warrants equal to 5% of ADSs placed, with an exercise price of $10.31 per ADS.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or existing debt levels.
Material Changes and Transaction Terms
The primary material change is the execution of Securities Purchase Agreements for the registered direct offering. Key terms include:
- Warrant Exercise: Warrants are exercisable immediately for 12 months from the earlier of the registration statement effectiveness or 6 months from issuance. Cashless exercise is permitted if no effective registration statement exists.
- Registration Delay Payments: If the registration statement for warrant shares is not effective within 60 days of closing, the Company must pay monthly penalties of 1.5% of the purchase price, capped at 8%.
- Lock-Up Provisions: A 45-day blackout period on issuing new securities and a one-year prohibition on "variable rate transactions."
Outlook, Risks, and Contingencies
The closing of the offering is subject to customary conditions and contingencies. The filing includes a warning concerning forward-looking statements, noting that the expected closing date is not guaranteed. If conditions are not satisfied, the offering may not close. The Company has agreed to use best efforts to file a registration statement by February 28, 2018, and have it declared effective within 60 days of closing.
Investor Verification Checklist
- Confirm the actual closing date of the offering and whether all customary conditions were satisfied.
- Verify the filing and effectiveness date of the registration statement for the warrant shares to assess potential registration delay payments.
- Review the impact of the 484,848 new ADSs and 266,667 warrant shares on existing shareholder dilution.
- Check subsequent filings for the utilization of the $4.0 million gross proceeds.